Eli Lilly’s $6 Billion Huntsville Plant: 450 High‑Paying Jobs, GLP‑1 Drug Boom and Alabama’s Biggest Industrial Bet
HUNTSVILLE, Ala. — December 9, 2025 Eli Lilly and Company will invest more than $6 billion in a new advanced pharmaceutical manufacturing campus in Huntsville, Alabama, creating 450 high‑value permanent jobs and an estimated 3,000 construction jobs in what state leaders are calling the largest initial private industrial investment in Alabama history. City of Huntsville+2governor.alabama.gov+2 The facility, planned for a 260‑acre site at the northeast corner of I‑565 and Greenbrier Parkway in Huntsville‑Limestone County, will manufacture active pharmaceutical ingredients (APIs) for small‑molecule and peptide medicines, including orforglipron, Lilly’s first oral GLP‑1 obesity drug now heading toward global regulatory submissions. City